References
- Shanmugaratnam K, Chan S H, de-Thé G, et al. Histopathology of nasopharyngeal carcinoma. Cancer 1979; 44: 1029–44
- Waterhouse J, Muir C, Shanmugaratnam K, et al. Cancer incidence in five continents Vol. IV. WHO. 1ARC Scientific Publications., Lyons 1982; 602–3
- Reedman B M, Klein G. Cellular localisation of an Epstein-Barr virus (EBV)–associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer 1973; 11: 499–520
- Gajwani B W, Devereaux J M, Beg J A. Familial clustering of nasopharyngeal carcinoma. Cancer 1980; 46: 2325–7
- Lanier A, Bender T, Talbot M, et al. Nasopharyngeal carcinoma in Alaskan eskimos, Indians and Aleuts. Cancer 1980; 46: 2100–6
- Simons M J, Shanmugaratnam K. The biology of nasopharyngeal carcinoma. U1CC Technical Report Series Vol 71. International Union against Cancer. Geneva. 1982, (a) 46 (b) 51.
- Veltri R W, Shah S H, McClung J E. Epstein-Barr virus, fatal infectious mononucleosis and Hodgkin's disease in siblings. Cancer 1983; 51: 509–20
- Fenner F J, White D O. Medical virology, 2nd ed. Academic Press Inc., New York 1976; 314–9
- Simons M J, Wee G B, Chan S H, et al. Probable identification of an HLA second locus antigen associated with a high risk of nasopharyngeal carcinoma. Lancet 1975; 1: 142–3
- Shanmugaratnam K. Nasopharynx. Cancer epidemiology and prevention, D. Schottenfeld, J F. Fraumeni. Saunders, Philadelphia 1982; 536–49